HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target

Histone deacetylases (HDACs) are involved in tumor progression, and some have been successfully targeted for cancer therapy. The expression of histone deacetylase 4 (HDAC4), a class IIa HDAC, was upregulated in our previous microarray screen. However, the role of HDAC4 dysregulation and mechanisms u...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chun, Yang, Jun, Li, Si-Wei, Huang, Guofu, Li, Chenxi, Min, Wei-Ping, Sang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862285/
https://www.ncbi.nlm.nih.gov/pubmed/33542203
http://dx.doi.org/10.1038/s41419-021-03417-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862285/
https://www.ncbi.nlm.nih.gov/pubmed/33542203
http://dx.doi.org/10.1038/s41419-021-03417-0

Ejemplares similares